1
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study
Condition(s):COVID-19 PandemicLast Updated:September 2, 2022Active, not recruiting
Recombinant SARS-CoV-2 Fusion Protein Vaccine: 9 Clinical Trials
Hide Studies Not Open or Pending
2
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III
Condition(s):COVID-19 PandemicLast Updated:September 2, 2022Active, not recruiting
3
Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity
Condition(s):COVID-19 PandemicLast Updated:March 3, 2022Active, not recruiting
4
Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization
Condition(s):COVID-19 PandemicLast Updated:November 18, 2021Active, not recruiting
5
Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
Condition(s):COVID19Last Updated:February 14, 2022Completed
6
Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine
Condition(s):COVID-19 PandemicLast Updated:March 29, 2022Active, not recruiting
7
The Immunogenicity and Safety of V-01-351/V-01D Bivalence Vaccine
Condition(s):COVID-19 PandemicLast Updated:March 10, 2022Active, not recruiting
8
A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5
Condition(s):COVID-19 PandemicLast Updated:November 7, 2022Active, not recruiting
9
Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19)
Condition(s):Covid19Last Updated:October 21, 2021Not yet recruiting